Open AccessA Closer Look at the Future of Immune Checkpoint Inhibitors
Author(s) -
Dibash Kumar Das
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000789340.67076.22
Subject(s) - ipilimumab , atezolizumab , nivolumab , pembrolizumab , immunotherapy , medicine , cancer immunotherapy , immune system , immune checkpoint , tumor microenvironment , cancer , immunology , pd l1 , cancer research